Monday, 30 July 2012

Novartis drug Afinitor wins EU nod to treat breast cancer



A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel ZURICH (Reuters) - Novartis said on Monday European regulators approved Afinitor to treat women with a certain type of breast cancer, following a panel backing in June. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. ...




via Health News Headlines - Yahoo! News Read More Here..

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)